Several in vitro studies revealed that uterine leiomyoma cells harbor intrinsic aromatase activity, thereby providing a direct source of steroid hormone to drive further growth through the development of an aberrant extracellular matrix [40]. The gene discussed is CYP19A1; the disease is Uterine leiomyoma.